Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onyda XR in Children with ADHD and ODD
NCT07044609Phase 4Not yet recruiting
- Sponsor
- Vector Clinical Trials
- Start
- Jul 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of clindamycin in attention deficit hyperactivity disorder (ADHD), oppositional defiant disorder (ODD), sponsored by Vector Clinical Trials. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
clindamycin
03
Conditions
attention deficit hyperactivity disorder (ADHD)oppositional defiant disorder (ODD)
Beyond the preview
Go deeper on NCT07044609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07044609.